Filter News
Area of Research
News Topics
- (-) Biomedical (2)
- (-) Grid (1)
- (-) Isotopes (2)
- (-) Nuclear Energy (2)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (1)
- Artificial Intelligence (3)
- Bioenergy (3)
- Biology (3)
- Buildings (1)
- Chemical Sciences (9)
- Composites (1)
- Computer Science (2)
- Coronavirus (1)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (11)
- Environment (2)
- Exascale Computing (1)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (2)
- Machine Learning (1)
- Materials (12)
- Materials Science (5)
- Microscopy (3)
- Nanotechnology (5)
- National Security (2)
- Neutron Science (5)
- Partnerships (4)
- Physics (6)
- Polymers (2)
- Quantum Science (1)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
Marc-Antoni Racing has licensed a collection of patented energy storage technologies developed at ORNL. The technologies focus on components that enable fast-charging, energy-dense batteries for electric and hybrid vehicles and grid storage.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.
Scientists at the Department of Energy’s Oak Ridge National Laboratory used neutrons, isotopes and simulations to “see” the atomic structure of a saturated solution and found evidence supporting one of two competing hypotheses about how ions come
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.